Prior Auth Required

1635G - p.E545D [g. >T only], p.E545G, p.E545K, p.Q546E, p.Q546R, p.H1047L, p.H1047R

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicep.E545D [g. >T only], p.E545G, p.E545K, p.Q546E, p.Q546R, p.H1047L, p.H1047R
Procedure / Service Description

hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to - Oncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) (eg, breast cancer) gene analysis (ie, p.C420R, p.E542K, p.E545A, p.E545D [g.1635G>T only], p.E545G, p.E545K, p.Q546E, p.Q546R, p.H1047L, p.H1047R, p.H1047Y), utilizing formalin-fixed paraffin-embedded breast tumor tissue, reported as PIK3CA 0155U gene mutation status

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.